BioSpace: GigaGen Works to Develop Passive, Convalescent COVID-19 Therapy

GigaGen is developing a recombinant polyclonal antibody therapy (rCIG) to treat COVID-19. First uses are envisioned as treatments for severely ill coronavirus patients and individuals at high risk of contracting the disease, including healthcare professionals.

Read the full story.